Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
Among the patients classified as EMA-GPA or EMA-unclassifiable, older patients with MPO-ANCA and ILD tended to be reclassified as 2022-MPA. The 2022 ACR/EULAR criteria were more useful in prognostic prediction than the EMA algorithm.
Authors
- Yuko Kaneko (ORCID: https://orcid.org/0000-0003-2646-5765)
- Katsuya Suzuki (ORCID: https://orcid.org/0009-0008-2930-5365)
- Mitsuhiro Akiyama (ORCID: https://orcid.org/0000-0001-5075-8977)
- Kotaro Matsumoto (ORCID: https://orcid.org/0000-0003-2047-7626)
- Yuki Imai (ORCID: https://orcid.org/0000-0003-0729-9810)
- Yuichiro Ota
Institutions
- University of Mary (US)
- Tokai University (JP)
- Keio University (JP)
- Tokyo Medical Center (JP)
- Tokyo National Hospital (JP)
Publication Details
- Journal
- The Journal of Rheumatology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.3899/jrheum.2024-0335
- Citations
- 4
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.68